Data / Form D filings / TREVENA INC
TREVENA INC: Form D filings
TREVENA INC, a pharmaceuticals company in King Of Prussia, PA, filed 2 Form D notices with the SEC between 2010 and 2013. The latest, on May 17, 2013, reports $60 million sold of a $60 million offering to 9 investors.
Find out what TREVENA INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1018 WEST 8TH AVENUE, SUITE A, King Of Prussia, PA, 19406
- Phone
- (610) 354-8840
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1429560
The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 17, 2013 | New notice | $60,000,000 | $59,999,997 | $3 | 9 | May 3, 2013 | sec.gov |
| Jul 16, 2010 | New notice | $41,000,000 | $17,500,000 | $23,500,000 | 8 | Jul 8, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Farah Champsi | Director | |
| David Solomon | Director | |
| Christopher Mirabelli | Director | |
| Robert Garland | Director | |
| Maxine Gowen | Executive Officer, Director | |
| Terence McGuire | Director | |
| Lonnie Moulder, Jr. | Director |
Other pharmaceuticals companies in Pennsylvania that filed recently
- Telemachus Therapeutics, Inc. $375,000 · Oct 28, 2026
- EpiVario Inc. $185,000 · Oct 13, 2026
- Maxona Pharmaceuticals, Inc. $5.8 million · Aug 14, 2026
Every Form D from the week of May 13, 2013 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what TREVENA INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.